RxDoctor Payments Data

Richard Meyer, MD

Orthopaedic Surgery · New Orleans, LANPI 1588664718

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (57.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medical Device Business Services, Inc. accounts for 64.7% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $8,343 and has fallen 95.4% since, to $382 in 2025.

$15,688in general payments, 2019–2025

Across 91 payments — averaging $172.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$10K
  • Stryker$3K
  • ALON Medical Technology$1K
  • Johnson & Johnson$519
  • Davol Inc.$167
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$107
  • plus $588 from 13 others

What the payments were for

  • Consulting fees$9,00057%
  • Travel & lodging$1,86212%
  • Food & beverage$3,79924%
  • Education$1,0277%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,688 in reported general payments places this provider in the 80th percentile of 286 orthopaedic surgery providers in Louisiana.

See all orthopaedic surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$198,490
Medicare patients
392
Services billed
11,488

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin426$3,441
Diclofenac Sodium291$3,231
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen141$2,630
Celecoxib128$1,515
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen61$908
Mupirocin104$799
Methylprednisolone85$599
Diclofenac Sodium ErDiclofenac Sodium14$576
Tramadol Hcl105$508
Tizanidine Hcl53$425
Ibuprofen38$377
Pregabalin84$360
Cephalexin53$327
Dexamethasone98$323
Meloxicam82$208

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →